Baric Transcribed Interview (Redacted) — page 114

DC.Scheduling@LexitasLegal.com DR. BARIC: Yeah, okay, I remember that. No, it's a different thing. MS. SALAZAR: So you didn't end up -- DR. BARIC: That was never funded. Yeah, we discussed it with them, and I actually think a proposal was written, and they were thinking about funding it, and then the program officer left, and the next program officer said they weren't interested in it, and that was the end of it. MS. SALAZAR: So then the dengue program, it was under the Pandemic Prevention Path, the platform P3. DR. BARIC: It's funny around that grant. That grant went to the Pacific Northwest Labs, and then they asked me to participate on dengue virus with it. So I don't know the name of the request. MS. SALAZAR: Okay. Have you ever done any work with any laboratories in Sri Lanka? DR. BARIC: Sri Lanka. MS. SALAZAR: Mm-hmm. DR. BARIC: A good collaborator that I have, who is Aravinda de Silva, who came from Sri Lanka, has connections there. And I've been funded with Aravinda and Eva Harris for a variety of dengue research and Zika research. So serum samples, we've gotten serum samples from both Sri Lanka and from the Philippines and from Nicaragua to do studies on flavivirus evolution, and identifying major